Re-investigation of the concordance of human NAT2 phenotypes and genotypes
- 177 Downloads
A comparative study of N-acetyltransferase 2 (NAT2) genotyping and phenotyping (caffeine test method) was performed on 211 persons to elucidate apparent discrepancies in the assignment of NAT2*12 and NAT2*13 alleles which occur in the literature. The study used the standard procedures of genotyping (two PCR runs and application of seven restriction enzymes) and phenotyping (determination of the two caffeine metabolites 5-acetylamino-6-formylamino-3-methyluracil (AFMU) and 1-methylxanthine (1X)), as documented in detail and validated by the Deutsche Forschungsgemeinschaft. The data were consistent with an AFMU/1X molar ratio of 0.85 as cut-off point (antimode) between phenotypically slow and rapid acetylators. Under this provision, several R/S allele combinations did not comply, either fully or partly, with their associated phenotypes. In particular, there was a wide phenotypic overlap of the alleged rapid allele combination groups (i) NAT2*12A/*5A; NAT2*12C/*5D; NAT2*4/*5B, (ii) NAT2*13/*6B; NAT2*4/*6A, and (iii) NAT2*13/*7A; NAT2*4/*7B. These groups obviously contained both phenotypically rapid and slow acetylators. If one assumes that the presence of one “wild type” allele NAT2*4 defines a rapid acetylator the assignment of the alleles NAT2*12A, NAT2*12C, and NAT*13 as determinants of a rapid acetylator phenotype must be questioned. This refers in particular to the nucleotide changes A803G (NAT2*12A, NAT2*12C) and C282T (NAT2*13). Based on discussions in the literature and the data presented here, there is accumulating evidence that current assignments of the NAT2*12 and NAT2*13 alleles as determinants of a rapid acetylator state should be reconsidered.
KeywordsN-Acetyltransferase 2 NAT2 Genotyping Phenotyping Caffeine test
The financial support of the Deutsche Forschungsgemeinschaft (SFB 475, “Reduction of complexity in multivariate data structures”) is gratefully acknowledged.
- Braz Vieira de Silva Pontes Z, Vincent-Viry M, Gueguen R, Gatteau MM, Siest G (1992) Acetylation phenotypes and biological variation in a French Caucasian population. Eur J Clin Biochem 31:59–67Google Scholar
- DFG, Deutsche Forschungsgemeinschaft (2004a) N-Acetyltransferase 2 (genotyping). In: Angerer J, Müller M, Weiss T et al. (eds) Analyses of hazardous substances in biological materials, vol 9: Special issue: Markers of susceptibility. Wiley–VCH, Weinheim, pp 135–163Google Scholar
- DFG, Deutsche Forschungsgemeinschaft (2004b) N-Acetyltransferase 2 (phenotyping). In: Angerer J, Müller M, Weiss T et al. (eds) Analyses of hazardous substances in biological materials, vol 9: Special issue: Markers of susceptibility. Wiley–VCH, Weinheim, pp 165–182Google Scholar
- Röhrkasten R, Raatz P, Kreher RP, Blaszkewicz M (1997) Synthesis of the caffeine metabolites 5-acetylamino-6-formylamino-3-methyluracil (AFMU) and 5-acetylamino-6-amino-3-methyluracil (AAMU) on a preparative scale. Z Naturforsch 52b:1526–1532Google Scholar